` RADX (Radiopharm Theranostics Ltd) vs MSB (Mesoblast Ltd) Comparison - Alpha Spread

RADX
vs
MSB

Over the past 12 months, RADX has underperformed MSB, delivering a return of -74% compared to the MSB's 66% growth.

Valuation Comparison

R
RADX Intrinsic Value
45.92 USD
Undervaluation 90%
Intrinsic Value
Price
MSB Intrinsic Value
1.11 AUD
Overvaluation 31%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
R
Radiopharm Theranostics Ltd
NASDAQ:RADX
4.64 USD
Mesoblast Ltd
ASX:MSB
1.61 AUD

Financials Comparison

Growth Over Time
RADX vs MSB

RADX
MSB
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
R
Radiopharm Theranostics Ltd
Revenue
Mesoblast Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
RADX vs MSB

RADX
MSB
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
R
Radiopharm Theranostics Ltd
NASDAQ:RADX
Mesoblast Ltd
ASX:MSB
What is Free Cash Flow?

Gross Margin

RADX
-13.7%
MSB
201.8%

Operating Margin

RADX
-2 243.8%
MSB
-1 414.4%

Net Margin

RADX
-2 490.7%
MSB
-1 822.8%

FCF Margin

RADX
-1 985.8%
MSB
-753.5%

ROE

RADX
-108.3%
MSB
-21.3%

ROA

RADX
-53.8%
MSB
-15.6%

ROIC

RADX
-70.4%
MSB
-13.5%

ROCE

RADX
-58.2%
MSB
-13.2%

Stocks Performance

Stocks Performance
RADX vs MSB

Loading

Performance Gap
RADX vs MSB

Loading
RADX
MSB
Difference
www.alphaspread.com

Performance By Year
RADX vs MSB

Loading
RADX
MSB
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account